Southeast Asset Advisors Inc. Merck & Co., Inc. Transaction History

Southeast Asset Advisors Inc.

$897 Million
Q3 2024

A detailed history of Southeast Asset Advisors Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Southeast Asset Advisors Inc. holds 7,655 shares of MRK stock, worth $759,222. This represents 0.1% of its overall portfolio holdings.

Number of Shares

7,655

Previous 7,649 0.08%

Holding current value

$759,222

Previous $946,000 8.14%

% of portfolio

0.1%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $666 - $773	6 Added 0.08%	7,655 $869,000
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $3,342 - $3,589	-27 Reduced 0.35%	7,649 $946,000
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $55,940 - $65,183	-494 Reduced 6.05%	7,676 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $801 - $872	8 Added 0.1%	8,170 $890,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $54,254 - $60,251	-527 Reduced 6.07%	8,162 $840,000
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $760 - $828	7 Added 0.08%	8,689 $1 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $7,308 - $8,155	71 Added 0.82%	8,682 $923,000
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $786 - $1,008	9 Added 0.1%	8,611 $955,000
Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $3,550 - $3,988	42 Added 0.49%	8,602 $741,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $667 - $757	8 Added 0.09%	8,560 $780,000
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $15,878 - $17,798	-216 Reduced 2.46%	8,552 $702,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $202,817 - $254,055	2,806 Added 47.06%	8,768 $672,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $17,848 - $19,628	-249 Reduced 4.01%	5,962 $448,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $632 - $699	9 Added 0.15%	6,211 $483,000
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $550 - $648	8 Added 0.13%	6,202 $478,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $502 - $557	7 Added 0.11%	6,194 $507,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $1,244 - $1,410	-17 Reduced 0.27%	6,187 $513,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $71,265 - $81,091	1,012 Added 19.49%	6,204 $480,000
Q1 2020 Apr 10, 2020	BUY	$63.36 - $87.82 $443 - $614	7 Added 0.14%	5,192 $399,000
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $465 - $525	6 Added 0.12%	5,185 $472,000
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $12,933 - $14,098	-170 Reduced 3.18%	5,179 $436,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $8,380 - $9,790	120 Added 2.29%	5,349 $449,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $8,210 - $9,364	-118 Reduced 2.21%	5,229 $435,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $13,469 - $15,825	265 Added 5.21%	5,347 $325,000
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $35,672 - $41,461	-700 Reduced 12.11%	5,082 $277,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $18,273 - $21,820	354 Added 6.52%	5,782 $325,000
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $318,460 - $342,669	5,428	5,428 $348,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Southeast Asset Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Southeast Asset Advisors Inc. with notifications on news.

Account

Southeast Asset Advisors Inc. Merck & Co., Inc. Transaction History